Fucosyltransferase 1 Mediates Angiogenesis in Rheumatoid Arthritis
dc.contributor.author | Isozaki, Takeo | en_US |
dc.contributor.author | Amin, Mohammad A. | en_US |
dc.contributor.author | Ruth, Jeffrey H. | en_US |
dc.contributor.author | Campbell, Phillip L. | en_US |
dc.contributor.author | Tsou, Pei‐suen | en_US |
dc.contributor.author | Ha, Christine M. | en_US |
dc.contributor.author | Stinson, W. Alex | en_US |
dc.contributor.author | Domino, Steven E. | en_US |
dc.contributor.author | Koch, Alisa E. | en_US |
dc.date.accessioned | 2014-08-06T16:49:34Z | |
dc.date.available | WITHHELD_13_MONTHS | en_US |
dc.date.available | 2014-08-06T16:49:34Z | |
dc.date.issued | 2014-08 | en_US |
dc.identifier.citation | Isozaki, Takeo; Amin, Mohammad A.; Ruth, Jeffrey H.; Campbell, Phillip L.; Tsou, Pei‐suen ; Ha, Christine M.; Stinson, W. Alex; Domino, Steven E.; Koch, Alisa E. (2014). "Fucosyltransferase 1 Mediates Angiogenesis in Rheumatoid Arthritis." Arthritis & Rheumatology 66(8): 2047-2058. | en_US |
dc.identifier.issn | 2326-5191 | en_US |
dc.identifier.issn | 2326-5205 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/108009 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Fucosyltransferase 1 Mediates Angiogenesis in Rheumatoid Arthritis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Rheumatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/108009/1/art38648.pdf | |
dc.identifier.doi | 10.1002/art.38648 | en_US |
dc.identifier.source | Arthritis & Rheumatology | en_US |
dc.identifier.citedreference | Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoattractant protein‐1 in rheumatoid arthritis. J Clin Invest 1992; 90: 772 – 9. | en_US |
dc.identifier.citedreference | Marotte H, Tsou PS, Rabquer BJ, Pinney AJ, Fedorova T, Lalwani N, et al. Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α–induced interleukin‐18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin‐18 binding protein a: role of the nuclear interferon regulatory factor 1–NF‐κB–c‐jun complex. Arthritis Rheum 2011; 63: 3253 – 62. | en_US |
dc.identifier.citedreference | Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK III, Imhof BA, et al. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 2008; 58: 3020 – 9. | en_US |
dc.identifier.citedreference | Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 2001; 159: 1521 – 30. | en_US |
dc.identifier.citedreference | Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. Evidence of IL‐18 as a novel angiogenic mediator. J Immunol 2001; 167: 1644 – 53. | en_US |
dc.identifier.citedreference | Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE. Migration inhibitory factor mediates angiogenesis via mitogen‐activated protein kinase and phosphatidylinositol kinase. Circ Res 2003; 93: 321 – 9. | en_US |
dc.identifier.citedreference | Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S. Green tea extract inhibits chemokine production, but up‐regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant‐induced arthritis. Rheumatology (Oxford) 2010; 49: 467 – 79. | en_US |
dc.identifier.citedreference | Macartney JC. Fucose‐containing antigens in normal and neoplastic human gastric mucosa: a comparative study using lectin histochemistry and blood group immunohistochemistry. J Pathol 1987; 152: 23 – 30. | en_US |
dc.identifier.citedreference | Hachicha M, Rathanaswami P, Schall TJ, McColl SR. Production of monocyte chemotactic protein–1 in human type B synoviocytes: synergistic effect of tumor necrosis factor α and interferon‐γ. Arthritis Rheum 1993; 36: 26 – 34. | en_US |
dc.identifier.citedreference | Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998; 89: 44 – 53. | en_US |
dc.identifier.citedreference | Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS‐PROT database. Biochim Biophys Acta 1999; 1473: 4 – 8. | en_US |
dc.identifier.citedreference | Hakomori S. Aberrant glycosylation in tumors and tumor‐associated carbohydrate antigens. Adv Cancer Res 1989; 52: 257 – 331. | en_US |
dc.identifier.citedreference | Nakagawa T, Uozumi N, Nakano M, Mizuno‐Horikawa Y, Okuyama N, Taguchi T, et al. Fucosylation of N‐glycans regulates the secretion of hepatic glycoproteins into bile ducts. J Biol Chem 2006; 281: 29797 – 806. | en_US |
dc.identifier.citedreference | Przybysz M, Maszczak D, Borysewicz K, Szechinski J, Katnik‐Prastowska I. Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis. Glycoconj J 2007; 24: 543 – 50. | en_US |
dc.identifier.citedreference | Ferens‐Sieczkowska M, Kossowska B, Gancarz R, Dudzik D, Knas M, Popko J, et al. Fucosylation in synovial fluid as a novel clinical marker for differentiating joint diseases: a preliminary study. Clin Exp Rheumatol 2007; 25: 92 – 5. | en_US |
dc.identifier.citedreference | Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, et al. Human endothelial cells express CCR2 and respond to MCP‐1: direct role of MCP‐1 in angiogenesis and tumor progression. Blood 2000; 96: 34 – 40. | en_US |
dc.identifier.citedreference | Isozaki T, Ruth JH, Amin MA, Campbell PL, Tsou PS, Ha CM, et al. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Res Ther 2014; 16: R28. | en_US |
dc.identifier.citedreference | Proost P, Struyf S, Couvreur M, Lenaerts JP, Conings R, Menten P, et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP‐1 and MCP‐2: identification of MCP‐2(6‐76) as a natural chemokine inhibitor. J Immunol 1998; 160: 4034 – 41. | en_US |
dc.identifier.citedreference | Carlyon JA, Akkoyunlu M, Xia L, Yago T, Wang T, Cummings RD, et al. Murine neutrophils require α1,3‐fucosylation but not PSGL‐1 for productive infection with Anaplasma phagocytophilum. Blood 2003; 102: 3387 – 95. | en_US |
dc.identifier.citedreference | Mathieu S, Gerolami R, Luis J, Carmona S, Kol O, Crescence L, et al. Introducing α(1,2)‐linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth. Int J Cancer 2007; 121: 1680 – 9. | en_US |
dc.identifier.citedreference | Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, et al. RNA‐mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem 2010; 111: 229 – 38. | en_US |
dc.identifier.citedreference | Tsou PS, Ruth JH, Campbell PL, Isozaki T, Lee S, Marotte H, et al. A novel role for inducible Fut2 in angiogenesis. Angiogenesis 2013; 16: 195 – 205. | en_US |
dc.identifier.citedreference | Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 2012; 13: 448 – 62. | en_US |
dc.identifier.citedreference | Moelants EA, Mortier A, Grauwen K, Ronsse I, Van Damme J, Proost P. Citrullination of TNF‐α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines. Cytokine 2013; 61: 161 – 7. | en_US |
dc.identifier.citedreference | Hart GW. Glycosylation. Curr Opin Cell Biol 1992; 4: 1017 – 23. | en_US |
dc.identifier.citedreference | Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004; 95: 377 – 84. | en_US |
dc.identifier.citedreference | Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008; 143: 725 – 9. | en_US |
dc.identifier.citedreference | Fukushima K, Satoh T, Baba S, Yamashita K. α1,2‐Fucosylated and β‐N‐acetylgalactosaminylated prostate‐specific antigen as an efficient marker of prostatic cancer. Glycobiology 2010; 20: 452 – 60. | en_US |
dc.identifier.citedreference | Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, et al. Targeting anticancer drug delivery to pancreatic cancer cells using a fucose‐bound nanoparticle approach. PLoS One 2012; 7: e39545. | en_US |
dc.identifier.citedreference | Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secretor blood group α(1,2)fucosyltransferase gene (FUT2): homozygosity for an enzyme‐inactivating nonsense mutation commonly correlates with the non‐secretor phenotype. J Biol Chem 1995; 270: 4640 – 9. | en_US |
dc.identifier.citedreference | Larsen RD, Ernst LK, Nair RP, Lowe JB. Molecular cloning, sequence, and expression of a human GDP‐L‐fucose:β‐D‐galactoside 2‐α‐L‐fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci U S A 1990; 87: 6674 – 8. | en_US |
dc.identifier.citedreference | Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E‐selectin and vascular cell adhesion molecule‐1. Nature 1995; 376: 517 – 9. | en_US |
dc.identifier.citedreference | Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, et al. Ley/H: an endothelial‐selective, cytokine‐inducible, angiogenic mediator. J Immunol 2000; 164: 4868 – 77. | en_US |
dc.identifier.citedreference | Zhu K, Amin MA, Kim MJ, Katschke KJ Jr, Park CC, Koch AE. A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte‐endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem 2003; 278: 21869 – 77. | en_US |
dc.identifier.citedreference | Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL‐8. J Immunol 1991; 147: 2187 – 95. | en_US |
dc.identifier.citedreference | Ritchlin C. Fibroblast biology: effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000; 2: 356 – 60. | en_US |
dc.identifier.citedreference | Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, et al. Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003; 48: 35 – 45. | en_US |
dc.identifier.citedreference | Mori K, Iida S, Yamane‐Ohnuki N, Kanda Y, Kuni‐Kamochi R, Nakano R, et al. Non‐fucosylated therapeutic antibodies: the next generation of therapeutic antibodies. Cytotechnology 2007; 55: 109 – 14. | en_US |
dc.identifier.citedreference | Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931 – 4. | en_US |
dc.identifier.citedreference | Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932 – 6. | en_US |
dc.identifier.citedreference | Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB. Deficiency of reproductive tract α(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 α(1,2)fucosyltransferase locus. Mol Cell Biol 2001; 21: 8336 – 45. | en_US |
dc.identifier.citedreference | Domino SE, Zhang L, Lowe JB. Molecular cloning, genomic mapping, and expression of two Secretor blood group α(1,2)fucosyltransferase genes differentially regulated in mouse uterine epithelium and gastrointestinal tract. J Biol Chem 2001; 276: 23748 – 56. | en_US |
dc.identifier.citedreference | Iwamori M, Domino SE. Tissue‐specific loss of fucosylated glycolipids in mice with targeted deletion of α(1,2)fucosyltransferase genes. Biochem J 2004; 380: 75 – 81. | en_US |
dc.identifier.citedreference | Marelli‐Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI. Isolation of endothelial cells from murine tissue. J Immunol Methods 2000; 244: 205 – 15. | en_US |
dc.identifier.citedreference | Ruth JH, Volin MV, Haines GK III, Woodruff DC, Katschke KJ Jr, Woods JM, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant‐induced arthritis. Arthritis Rheum 2001; 44: 1568 – 81. | en_US |
dc.identifier.citedreference | Isozaki T, Rabquer BJ, Ruth JH, Haines GK III, Koch AE. ADAM‐10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis. Arthritis Rheum 2013; 65: 98 – 108. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.